{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-030228","form_type":"8-K","ticker":"NRXP","cik":"0001719406","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-09-14T12:00:11+00:00","discovered_at":"2026-09-14T12:05:00.759607+00:00","generated_at":"2026-09-14T12:05:53.496258+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"NRx Pharmaceuticals furnishes investor presentation with no material new details","bullets":["Furnished updated investor presentation for meetings starting Sept 8, 2026.","Presentation may be used in future investor and analyst meetings with modifications.","No financial or operational specifics disclosed in the 8-K body.","Exhibit content not available; no material changes to operations reported."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-030228","json":"https://secwatch.observer/filing/0001437749-26-030228.json","markdown":"https://secwatch.observer/filing/0001437749-26-030228.md","text":"https://secwatch.observer/filing/0001437749-26-030228.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926030228/0001437749-26-030228-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926030228/nrxp20260911_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-14T12:05:53.496258+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}